BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Press Releases

  Q1 2026: Strong Revenue Growth and Therapeutics Pipeline Advancement

  April 7, 2026

   · 

  13 min read
• Press Releases

  Renovare Therapeutics, Inc. Announces Company Launch and Collaboration with CU Boulder Awardee of up to $33.5 Million in ARPA-H Funding to Advance Osteoarthritis Regenerative Therapies

  April 7, 2026

   · 

  6 min read
• Press Releases

  Ascendis Receives Orphan Drug Exclusivity and Launches YUVIWEL® (Navepegritide) in the United States

  April 7, 2026

   · 

  9 min read
• Press Releases

  Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026

  April 7, 2026

   · 

  8 min read
• Press Releases

  Press Release: Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma and CRSwNP

  April 7, 2026

   · 

  11 min read
• Press Releases

  Ryoncil® Continues Successful First Year Launch with Net Sales of US$30.3M in March Quarter

  April 7, 2026

   · 

  6 min read
• Press Releases

  Leading Clinical Research and Abstract Submissions to Headline 2026 SGO Annual Meeting on Women’s Cancer in San Juan, Puerto Rico

  April 7, 2026

   · 

  4 min read
• Press Releases

  ABION Presents Preclinical Data at AACR Showing IFN-β Antibody Fusion ABN202 Outperforms TROP2-Targeting ADCs

  April 7, 2026

   · 

  1 min read
• Press Releases

  Organogenesis Achieves Primary Endpoint in Randomized Controlled Trial of PuraPly®AM

  April 7, 2026

   · 

  4 min read
• Press Releases

  Section 232 Pharmaceutical Tariffs - Biocom Statement

  April 7, 2026

   · 

  2 min read